A blood test to help guide the treatment of oesophageal, stomach and bowel cancers will be evaluated in a new Flinders University trial set to get underway. The blood test is currently offered under the brand name COLVERA® in the US as a tool to aid in the detection of cancer relapse after treatment.
[Flinders University]
7992332
{7992332:nan}
apa
50
1
164167
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
